Logo image of SCL

STEPAN CO (SCL) Stock Fundamental Analysis

NYSE:SCL - New York Stock Exchange, Inc. - US8585861003 - Common Stock - Currency: USD

48.24  -0.37 (-0.76%)

After market: 48.24 0 (0%)

Fundamental Rating

4

Overall SCL gets a fundamental rating of 4 out of 10. We evaluated SCL against 85 industry peers in the Chemicals industry. SCL has a bad profitability rating. Also its financial health evaluation is rather negative. SCL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SCL was profitable.
SCL had a positive operating cash flow in the past year.
Each year in the past 5 years SCL has been profitable.
SCL had a positive operating cash flow in each of the past 5 years.
SCL Yearly Net Income VS EBIT VS OCF VS FCFSCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.19%, SCL is in line with its industry, outperforming 55.29% of the companies in the same industry.
SCL's Return On Equity of 4.31% is in line compared to the rest of the industry. SCL outperforms 55.29% of its industry peers.
With a Return On Invested Capital value of 3.59%, SCL is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for SCL is in line with the industry average of 7.05%.
Industry RankSector Rank
ROA 2.19%
ROE 4.31%
ROIC 3.59%
ROA(3y)3.31%
ROA(5y)4.77%
ROE(3y)6.74%
ROE(5y)9.18%
ROIC(3y)5.63%
ROIC(5y)7.38%
SCL Yearly ROA, ROE, ROICSCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

SCL has a Profit Margin (2.31%) which is comparable to the rest of the industry.
SCL's Profit Margin has declined in the last couple of years.
SCL's Operating Margin of 3.23% is on the low side compared to the rest of the industry. SCL is outperformed by 68.24% of its industry peers.
In the last couple of years the Operating Margin of SCL has declined.
Looking at the Gross Margin, with a value of 12.49%, SCL is doing worse than 75.29% of the companies in the same industry.
In the last couple of years the Gross Margin of SCL has declined.
Industry RankSector Rank
OM 3.23%
PM (TTM) 2.31%
GM 12.49%
OM growth 3Y-24.2%
OM growth 5Y-14.3%
PM growth 3Y-26.73%
PM growth 5Y-16.07%
GM growth 3Y-9.55%
GM growth 5Y-7.34%
SCL Yearly Profit, Operating, Gross MarginsSCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SCL is destroying value.
SCL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SCL has about the same amount of shares outstanding.
The debt/assets ratio for SCL has been reduced compared to a year ago.
SCL Yearly Shares OutstandingSCL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SCL Yearly Total Debt VS Total AssetsSCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

SCL has an Altman-Z score of 2.47. This is not the best score and indicates that SCL is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of SCL (2.47) is better than 75.29% of its industry peers.
SCL has a debt to FCF ratio of 15.92. This is a negative value and a sign of low solvency as SCL would need 15.92 years to pay back of all of its debts.
The Debt to FCF ratio of SCL (15.92) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.28 indicates that SCL is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.28, SCL is doing good in the industry, outperforming 72.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 15.92
Altman-Z 2.47
ROIC/WACC0.43
WACC8.25%
SCL Yearly LT Debt VS Equity VS FCFSCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

SCL has a Current Ratio of 1.21. This is a normal value and indicates that SCL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.21, SCL is doing worse than 77.65% of the companies in the same industry.
SCL has a Quick Ratio of 1.21. This is a bad value and indicates that SCL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.78, SCL is doing worse than 74.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.78
SCL Yearly Current Assets VS Current LiabilitesSCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The earnings per share for SCL have decreased by -0.45% in the last year.
Measured over the past years, SCL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.51% on average per year.
The Revenue has decreased by -6.25% in the past year.
The Revenue has been growing slightly by 3.24% on average over the past years.
EPS 1Y (TTM)-0.45%
EPS 3Y-29.09%
EPS 5Y-15.51%
EPS Q2Q%-63.64%
Revenue 1Y (TTM)-6.25%
Revenue growth 3Y-2.41%
Revenue growth 5Y3.24%
Sales Q2Q%-1.23%

3.2 Future

SCL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.56% yearly.
Based on estimates for the next years, SCL will show a small growth in Revenue. The Revenue will grow by 6.64% on average per year.
EPS Next Y46.14%
EPS Next 2Y40.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.64%
Revenue Next 2Y5.88%
Revenue Next 3Y8.56%
Revenue Next 5Y6.64%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SCL Yearly Revenue VS EstimatesSCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
SCL Yearly EPS VS EstimatesSCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.93, which indicates a rather expensive current valuation of SCL.
SCL's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of SCL to the average of the S&P500 Index (28.79), we can say SCL is valued slightly cheaper.
A Price/Forward Earnings ratio of 15.00 indicates a correct valuation of SCL.
The rest of the industry has a similar Price/Forward Earnings ratio as SCL.
The average S&P500 Price/Forward Earnings ratio is at 21.38. SCL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.93
Fwd PE 15
SCL Price Earnings VS Forward Price EarningsSCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SCL.
SCL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 27.7
EV/EBITDA 8.83
SCL Per share dataSCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

SCL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SCL's earnings are expected to grow with 40.56% in the coming years.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y40.56%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

SCL has a Yearly Dividend Yield of 3.17%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of SCL has falen by -23.18%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 3.85, SCL pays a bit more dividend than its industry peers.
SCL's Dividend Yield is a higher than the S&P500 average which is at 2.47.
Industry RankSector Rank
Dividend Yield 3.17%

5.2 History

On average, the dividend of SCL grows each year by 8.06%, which is quite nice.
SCL has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of SCL decreased recently.
Dividend Growth(5Y)8.06%
Div Incr Years1
Div Non Decr Years1
SCL Yearly Dividends per shareSCL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

67.40% of the earnings are spent on dividend by SCL. This is not a sustainable payout ratio.
SCL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP67.4%
EPS Next 2Y40.56%
EPS Next 3YN/A
SCL Yearly Income VS Free CF VS DividendSCL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
SCL Dividend Payout.SCL Dividend Payout, showing the Payout Ratio.SCL Dividend Payout.PayoutRetained Earnings

STEPAN CO

NYSE:SCL (4/25/2025, 8:04:00 PM)

After market: 48.24 0 (0%)

48.24

-0.37 (-0.76%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-19 2025-02-19/bmo
Earnings (Next)04-29 2025-04-29/bmo
Inst Owners86.22%
Inst Owner Change-38.33%
Ins Owners4.64%
Ins Owner Change-2.61%
Market Cap1.09B
Analysts76.67
Price Target86.7 (79.73%)
Short Float %1.09%
Short Ratio1.65
Dividend
Industry RankSector Rank
Dividend Yield 3.17%
Yearly Dividend1.51
Dividend Growth(5Y)8.06%
DP67.4%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-03 2025-03-03 (0.385)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.48%
Min EPS beat(2)-65.06%
Max EPS beat(2)56.09%
EPS beat(4)2
Avg EPS beat(4)7.85%
Min EPS beat(4)-65.06%
Max EPS beat(4)79.76%
EPS beat(8)2
Avg EPS beat(8)-9.61%
EPS beat(12)6
Avg EPS beat(12)0.73%
EPS beat(16)8
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-3.98%
Min Revenue beat(2)-7.59%
Max Revenue beat(2)-0.36%
Revenue beat(4)0
Avg Revenue beat(4)-4.93%
Min Revenue beat(4)-7.59%
Max Revenue beat(4)-0.36%
Revenue beat(8)0
Avg Revenue beat(8)-5.5%
Revenue beat(12)4
Avg Revenue beat(12)-1.8%
Revenue beat(16)8
Avg Revenue beat(16)0.56%
PT rev (1m)-5.56%
PT rev (3m)-12.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.61%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.1%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)-2.85%
Valuation
Industry RankSector Rank
PE 21.93
Fwd PE 15
P/S 0.5
P/FCF 27.7
P/OCF 6.71
P/B 0.93
P/tB 1.05
EV/EBITDA 8.83
EPS(TTM)2.2
EY4.56%
EPS(NY)3.22
Fwd EY6.66%
FCF(TTM)1.74
FCFY3.61%
OCF(TTM)7.19
OCFY14.9%
SpS96.69
BVpS51.88
TBVpS45.94
PEG (NY)0.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.19%
ROE 4.31%
ROCE 4.31%
ROIC 3.59%
ROICexc 3.82%
ROICexgc 4.18%
OM 3.23%
PM (TTM) 2.31%
GM 12.49%
FCFM 1.8%
ROA(3y)3.31%
ROA(5y)4.77%
ROE(3y)6.74%
ROE(5y)9.18%
ROIC(3y)5.63%
ROIC(5y)7.38%
ROICexc(3y)6.06%
ROICexc(5y)8.61%
ROICexgc(3y)6.68%
ROICexgc(5y)9.41%
ROCE(3y)6.76%
ROCE(5y)8.87%
ROICexcg growth 3Y-28.84%
ROICexcg growth 5Y-19.33%
ROICexc growth 3Y-28.18%
ROICexc growth 5Y-20.06%
OM growth 3Y-24.2%
OM growth 5Y-14.3%
PM growth 3Y-26.73%
PM growth 5Y-16.07%
GM growth 3Y-9.55%
GM growth 5Y-7.34%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 15.92
Debt/EBITDA 1.82
Cap/Depr 109.43%
Cap/Sales 5.63%
Interest Coverage 2.36
Cash Conversion 88.71%
Profit Quality 77.98%
Current Ratio 1.21
Quick Ratio 0.78
Altman-Z 2.47
F-Score6
WACC8.25%
ROIC/WACC0.43
Cap/Depr(3y)225.06%
Cap/Depr(5y)209.82%
Cap/Sales(3y)9.23%
Cap/Sales(5y)8.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.45%
EPS 3Y-29.09%
EPS 5Y-15.51%
EPS Q2Q%-63.64%
EPS Next Y46.14%
EPS Next 2Y40.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.25%
Revenue growth 3Y-2.41%
Revenue growth 5Y3.24%
Sales Q2Q%-1.23%
Revenue Next Year5.64%
Revenue Next 2Y5.88%
Revenue Next 3Y8.56%
Revenue Next 5Y6.64%
EBIT growth 1Y-2.93%
EBIT growth 3Y-26.03%
EBIT growth 5Y-11.52%
EBIT Next Year226.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y145.96%
FCF growth 3YN/A
FCF growth 5Y-19.02%
OCF growth 1Y-7.33%
OCF growth 3Y30.97%
OCF growth 5Y-5.79%